CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-30 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Purchase | +84,041 | $9.75 | $819K | 468,585 |
| 2018-04-30 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Purchase | +172,626 | $9.75 | $1.7M | 962,504 |
| 2018-04-30 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Purchase | +93,333 | $9.75 | $910K | 520,396 |
| 2018-04-30 | Nussbaum Ran Director | Purchase | +84,041 | $9.75 | $819K | 468,585 |
| 2018-04-30 | Nussbaum Ran Director | Purchase | +172,626 | $9.75 | $1.7M | 962,504 |
| 2018-04-30 | Nussbaum Ran Director | Purchase | +93,333 | $9.75 | $910K | 520,396 |
| 2018-04-30 | Kleijwegt Martijn Director | Purchase | +300,000 | $9.75 | $2.9M | 2,953,673 |
| 2018-04-30 | Kariv Tomer Director | Purchase | +84,041 | $9.75 | $819K | 468,585 |
| 2018-04-30 | Kariv Tomer Director | Purchase | +172,626 | $9.75 | $1.7M | 962,504 |
| 2018-04-30 | Kariv Tomer Director | Purchase | +93,333 | $9.75 | $910K | 520,396 |
| 2018-04-04 | Shabtai Gilad 10% owner | Purchase | +2,600 | $9.58 | $25K | 3,276,770 |
| 2018-04-03 | Shabtai Gilad 10% owner | Purchase | +5,700 | $9.41 | $54K | 3,274,170 |
| 2018-03-29 | Shabtai Gilad 10% owner | Purchase | +4,500 | $9.64 | $43K | 3,268,470 |
| 2018-03-26 | Avnur Zafrira Director | Purchase | +2,000 | $9.49 | $19K | 2,263 |
| 2018-03-23 | Ward Robert Chief Executive Officer | Purchase | +10,000 | $8.99 | $90K | 10,000 |
| 2018-03-23 | WEAVER GREGORY L Chief Financial Officer | Purchase | +4,500 | $8.56 | $39K | 4,500 |
| 2018-03-22 | Nussbaum Ran Director | Purchase | +1,441 | $8.00 | $12K | 384,544 |
| 2018-03-22 | Nussbaum Ran Director | Purchase | +2,959 | $8.00 | $24K | 789,878 |
| 2018-03-22 | Nussbaum Ran Director | Purchase | +1,600 | $8.00 | $13K | 427,063 |
| 2018-03-22 | Kariv Tomer Director | Purchase | +1,441 | $8.00 | $12K | 384,544 |
Page 15 of 20 · 388 trades